Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8 D Porquet, G Casadesús, S Bayod, A Vicente, AM Canudas, J Vilaplana, ... Age 35, 1851-1865, 2013 | 279 | 2013 |
Memantine for the treatment of dementia: a review on its current and future applications J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ... Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018 | 247 | 2018 |
Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection M Pallàs, G Casadesús, MA Smith, A Coto-Montes, C Pelegri, J Vilaplana, ... Current neurovascular research 6 (1), 70-81, 2009 | 208 | 2009 |
Early amyloid accumulation in the hippocampus of SAMP8 mice J Del Valle, J Duran-Vilaregut, G Manich, G Casadesús, MA Smith, ... Journal of Alzheimer's Disease 19 (4), 1303-1315, 2010 | 150 | 2010 |
Increased permeability of blood–brain barrier on the hippocampus of a murine model of senescence C Pelegrí, AM Canudas, J del Valle, G Casadesus, MA Smith, A Camins, ... Mechanisms of ageing and development 128 (9), 522-528, 2007 | 107 | 2007 |
Trafficking of gold nanoparticles coated with the 8D3 anti-transferrin receptor antibody at the mouse blood–brain barrier I Cabezón, G Manich, R Martín-Venegas, A Camins, C Pelegrí, ... Molecular pharmaceutics 12 (11), 4137-4145, 2015 | 102 | 2015 |
Sirtuin activators: designing molecules to extend life span A Camins, FX Sureda, F Junyent, E Verdaguer, J Folch, C Pelegri, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799 (10-12 …, 2010 | 98 | 2010 |
Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid C Pelegrí, J Duran-Vilaregut, J del Valle, N Crespo-Biel, I Ferrer, M Pallàs, ... International Journal of Developmental Neuroscience 26 (7), 665-671, 2008 | 88 | 2008 |
Dissociation of the rat motor activity rhythm under T cycles shorter than 24 hours A Campuzano, J Vilaplana, T Cambras, A Díez-Noguera Physiology & behavior 63 (2), 171-176, 1998 | 78 | 1998 |
Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium A Camins, E Verdaguer, F Junyent, M Yeste‐Velasco, C Pelegrí, ... CNS neuroscience & therapeutics 15 (4), 333-344, 2009 | 72 | 2009 |
A method to quantify glial fibrillary acidic protein immunoreactivity on the suprachiasmatic nucleus J Vilaplana, M Lavialle Journal of neuroscience methods 88 (2), 181-187, 1999 | 70 | 1999 |
Characterization of amyloid-β granules in the hippocampus of SAMP8 mice G Manich, C Mercader, J Del Valle, J Duran-Vilaregut, A Camins, ... Journal of Alzheimer's disease 25 (3), 535-546, 2011 | 69 | 2011 |
Circadian rhythms in surface molecules of rat blood lymphocytes C Pelegrı́, J Vilaplana, C Castellote, M Rabanal, À Franch, M Castell American Journal of Physiology-Cell Physiology 284 (1), C67-C76, 2003 | 64 | 2003 |
Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases F X Sureda, F Junyent, E Verdaguer, C Auladell, C Pelegri, J Vilaplana, ... Current pharmaceutical design 17 (3), 230-245, 2011 | 63 | 2011 |
New perspectives on corpora amylacea in the human brain E Augé, I Cabezón, C Pelegrí, J Vilaplana Scientific Reports 7 (1), 41807, 2017 | 62 | 2017 |
A new method for determining blood–brain barrier integrity based on intracardiac perfusion of an Evans Blue–Hoechst cocktail J del Valle, A Camins, M Pallàs, J Vilaplana, C Pelegrí Journal of neuroscience methods 174 (1), 42-49, 2008 | 62 | 2008 |
Functioning of the rat circadian system is modified by light applied in critical postnatal days MM Canal-Corretger, J Vilaplana, T Cambras, A Díez-Noguera American Journal of Physiology-Regulatory, Integrative and Comparative …, 2001 | 62 | 2001 |
Cerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice J Del Valle, J Duran-Vilaregut, G Manich, M Pallàs, A Camins, J Vilaplana, ... Neurodegenerative Diseases 8 (6), 421-429, 2011 | 60 | 2011 |
Astrocytes and neurons produce distinct types of polyglucosan bodies in L afora disease E Augé, C Pelegrí, G Manich, I Cabezón, JJ Guinovart, J Duran, ... Glia 66 (10), 2094-2107, 2018 | 59 | 2018 |
Role of matrix metalloproteinase‐9 (MMP‐9) in striatal blood–brain barrier disruption in a 3‐nitropropionic acid model of huntington's disease J Duran‐Vilaregut, J Del Valle, G Manich, A Camins, M Pallàs, J Vilaplana, ... Neuropathology and applied neurobiology 37 (5), 525-537, 2011 | 56 | 2011 |